Education
About Us
Working with TipRanks
Follow Us
SI-Bone Inc (SIBN)
NASDAQ:SIBN
SIBN Stock Chart & Stats
Day’s Range― - ―
52-Week Range$11.70 - $20.05
Previous CloseN/A
Volume50.81K
Average Volume (3M)368.85K
Market Cap
$741.07M
Enterprise Value$486.73M
Total Cash (Recent Filing)$144.41M
Total Debt (Recent Filing)$37.15M
Price to Earnings (P/E)―
Beta0.96
Next Earnings
Aug 04, 2025EPS Estimate
-0.18Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.15
Shares Outstanding42,614,513
10 Day Avg. Volume286,863
30 Day Avg. Volume368,854
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap0.66
Enterprise Value/Revenue2.76
Enterprise Value/Gross Profit3.48
Enterprise Value/Ebitda-25.94
Forecast
1Y Price Target
$24.29Price Target Upside39.68% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering7
Bulls Say, Bears Say
Bulls Say
Earnings And Financial PerformanceSales and profit metrics for SIBN were nicely ahead of expectations, suggesting strong performance.
Product InnovationSIBN has received FDA Breakthrough Device Designation for its new Pelvic Fracture Fixation System, exceeding launch expectations and making SIBN the only public company in its industry granted three BDDs.
Surgeon EngagementThere were more than 1,400 active surgeons in Q1, up 27%, marking the largest increase in any quarter ever.
Bears Say
Operating LossSIBN's operating loss was significantly better than expected, showcasing improved financial management.
SI-Bone News
SIBN FAQ
What was SI-Bone Inc’s price range in the past 12 months?
SI-Bone Inc lowest stock price was $11.70 and its highest was $20.05 in the past 12 months.
What is SI-Bone Inc’s market cap?
SI-Bone Inc’s market cap is $741.07M.
When is SI-Bone Inc’s upcoming earnings report date?
SI-Bone Inc’s upcoming earnings report date is Aug 04, 2025 which is tomorrow.
How were SI-Bone Inc’s earnings last quarter?
SI-Bone Inc released its earnings results on May 05, 2025. The company reported -$0.15 earnings per share for the quarter, beating the consensus estimate of -$0.226 by $0.076.
Is SI-Bone Inc overvalued?
According to Wall Street analysts SI-Bone Inc’s price is currently Undervalued.
Does SI-Bone Inc pay dividends?
SI-Bone Inc does not currently pay dividends.
What is SI-Bone Inc’s EPS estimate?
SI-Bone Inc’s EPS estimate is -0.18.
How many shares outstanding does SI-Bone Inc have?
SI-Bone Inc has 42,614,513 shares outstanding.
What happened to SI-Bone Inc’s price movement after its last earnings report?
SI-Bone Inc reported an EPS of -$0.15 in its last earnings report, beating expectations of -$0.226. Following the earnings report the stock price went up 15.439%.
Which hedge fund is a major shareholder of SI-Bone Inc?
Currently, no hedge funds are holding shares in SIBN
SI-Bone Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$24.29 (39.68% Upside)
$24.29 (39.68% Upside)
Blogger Sentiment
Bullish
SIBN Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 124.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $662.3K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
17.18%
12-Months-Change
Fundamentals
Return on Equity
-15.96%
Trailing 12-Months
Asset Growth
1.59%
Trailing 12-Months
Company Description
SI-Bone Inc
SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fractures. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; and iFuse-TORQ, a set of 3D-printed threaded implants designed to treat fractures of the pelvis and for minimally invasive sacroiliac joint fusion. It markets its products primarily with a direct sales force, as well as through distributors. The company was incorporated in 2008 and is headquartered in Santa Clara, California.
SIBN Company Deck
SIBN Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted strong revenue growth, increased physician engagement, and improved gross margins, but also acknowledged challenges such as ongoing net losses, slow international revenue growth, and pending regulatory decisions. The overall sentiment is cautiously optimistic with strong operational performance but mindful of external conditions.Read More>SIBN Stock 12 Month Forecast
Average Price Target
$24.29
▲(39.68%Upside)
Technical Analysis
Ownership Overview
5.14% Insiders
30.26% Mutual Funds
1.53% Other Institutional Investors
52.14% Public Companies and
Individual Investors